Business Segments · Provision for income taxes
Pharmaceuticals — Provision for income taxes
Vertex Pharmaceuticals Pharmaceuticals — Provision for income taxes decreased by 35.2% to $139.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 37.4%, from $223.50M to $139.90M. Over 3 years (FY 2022 to FY 2025), Pharmaceuticals — Provision for income taxes shows a downward trend with a -8.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025
Rolls up toIncome Tax
How to read this metric
Changes reflect fluctuations in pre-tax profitability or shifts in the effective tax rate due to jurisdictional changes.
Detailed definition
The estimated tax expense calculated on the company's pre-tax earnings based on applicable tax jurisdictions. This refle...
Peer comparison
Standardized as 'Provision for Income Taxes' on the income statement.
Metric ID:
vrtx_segment_pharmaceuticals_provision_for_income_taxesHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $227.60M | $227.60M | $227.60M | $227.60M | $190.05M | $190.05M | $190.05M | $190.05M | $179.50M | $202.40M | $178.70M | $223.50M | $84.10M | $250.10M | $215.90M | $139.90M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -16.5% | +0.0% | +0.0% | +0.0% | -5.6% | +12.8% | -11.7% | +25.1% | -62.4% | +197.4% | -13.7% | -35.2% |
| YoY Change | — | — | — | — | -16.5% | -16.5% | -16.5% | -16.5% | -5.6% | +6.5% | -6.0% | +17.6% | -53.1% | +23.6% | +20.8% | -37.4% |
Range$84.10M – $250.10M
CAGR-12.2%
Avg YoY Growth-8.3%
Median YoY Growth-11.2%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pharmaceuticals — provision for income taxes?
- Vertex Pharmaceuticals (VRTX) reported pharmaceuticals — provision for income taxes of $139.90M in Q4 2025.
- How has Vertex Pharmaceuticals's pharmaceuticals — provision for income taxes changed year-over-year?
- Vertex Pharmaceuticals's pharmaceuticals — provision for income taxes decreased by 37.4% year-over-year, from $223.50M to $139.90M.
- What is the long-term trend for Vertex Pharmaceuticals's pharmaceuticals — provision for income taxes?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's pharmaceuticals — provision for income taxes has grown at a -8.8% compound annual growth rate (CAGR), from $910.40M to $690.00M.
- What does pharmaceuticals — provision for income taxes mean?
- The amount of money the company sets aside to pay income taxes.